Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Upstream Bio (UPB) Income from Continuing Operations (2023 - 2025)

Historic Income from Continuing Operations for Upstream Bio (UPB) over the last 3 years, with Q3 2025 value amounting to -$33.7 million.

  • Upstream Bio's Income from Continuing Operations fell 11095.13% to -$33.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$122.2 million, marking a year-over-year decrease of 11352.39%. This contributed to the annual value of -$65.6 million for FY2024, which is 8259.48% down from last year.
  • Latest data reveals that Upstream Bio reported Income from Continuing Operations of -$33.7 million as of Q3 2025, which was down 11095.13% from -$39.9 million recorded in Q2 2025.
  • Over the past 5 years, Upstream Bio's Income from Continuing Operations peaked at -$7.9 million during Q3 2023, and registered a low of -$39.9 million during Q2 2025.
  • For the 3-year period, Upstream Bio's Income from Continuing Operations averaged around -$20.8 million, with its median value being -$16.0 million (2024).
  • As far as peak fluctuations go, Upstream Bio's Income from Continuing Operations tumbled by 6581.06% in 2024, and later plummeted by 17222.26% in 2025.
  • Upstream Bio's Income from Continuing Operations (Quarter) stood at -$12.8 million in 2023, then plummeted by 65.81% to -$21.2 million in 2024, then tumbled by 58.78% to -$33.7 million in 2025.
  • Its Income from Continuing Operations stands at -$33.7 million for Q3 2025, versus -$39.9 million for Q2 2025 and -$27.3 million for Q1 2025.